SERPINA3 and metabolic syndrome: In summary, SERPINA3/Serpina3c, a serine (or cysteine) peptidase inhibitor, has demonstrated multifaceted regulatory roles in non-neoplastic diseases, including neurodegenerative disorders, cardiovascular diseases, inflammatory conditions, and metabolic syndrome.